Comparison
Agomelatine vs Melatonin
Agomelatine: designer mood+sleep restoration. Melatonin: pure circadian-shifting signal.
Agomelatine
Melatonergic Antidepressant (MT1/MT2 Agonist, 5-HT2C Antagonist)
Melatonin
Chronobiotic / Indoleamine
Effectiveness Profile
At a Glance
| Agomelatine | Melatonin | |
|---|---|---|
| Type | Nootropic | Longevity |
| Legal status | Rx-Only | OTC |
| Half-life | 1–2 hours | 40–60 minutes (IR oral); extended-release formulations prolong exposure across the night |
| Preferred route | Oral | Oral |
| Dose frequency | once-daily | once-daily |
| Beginner dose | 12.5–25 mg | 0.3–1 mg |
| Intermediate dose | 25–25 mg | 1–3 mg |
| Advanced dose | 25–50 mg | 3–5 mg |
| Cycle length | 4–24 wks | 1–52 wks |
| Bioavailability | 5% | 15% |
| Time to peak | 1.5h | 0.75h |
| Active duration | 4h | 4h |
| Storage | Room temperature, 15–25°C, dry | Room temperature, dark container; topical solutions refrigerated |
| PCT required | No | No |
| Ancillaries required | No | No |
| Safe for women | Yes | Yes |
Verdict
Agomelatine wins for restoring both sleep architecture and mood via dual MT1/MT2 agonism and 5-HT2C antagonism, rapidly resetting sleep disrupted by PED cycles or travel, and avoiding sexual or cognitive blunting typical of SSRIs. Its short half-life avoids next-day sedation.
Melatonin wins for pure circadian rhythm resynchronization, ultra-low side-effect burden at physiological doses, versatility in both sleep and non-sleep stacks (GH pulse amplification, topical hair growth, mild BP lowering), and essentially zero hepatic load, making it safe even with heavy oral AAS stacks.
Pick A or B?
Pick Agomelatine if:
- Sleep is disrupted by cycle stimulants (e.g., trenbolone, modafinil) and a mood reset is also needed.
- Mood, drive, or motivation is downregulated post-cycle but SSRIs/SNRIs are not viable due to sexual or cognitive side effects.
- There is a need for circadian resynchronization after travel or shift work, with rapid phase correction and non-sedating mornings.
- Hepatic tolerance is not a weak link (no oral 17α-AAS or major CYP1A2 inhibitors in the stack).
- Protocol allows for periodic LFT monitoring, with dosing discipline around hepatotoxicity.
Pick Melatonin if:
- The goal is naturalistic sleep onset support without affecting daytime dopamine or noradrenaline tone.
- GH protocol or nocturnal blood pressure reduction is being stacked, needing safe signal amplification.
- Side effect minimization and broad stack compatibility (including heavy oral AAS, polypharmacy) is paramount.
- Administration flexibility is needed (oral, sublingual, topical), including adjunctive use for hair.
- A proven, dirt-cheap profile is preferable for long-term, daily research application.